SCHEMBL504872

SCHEMBL504872

COc1cc(-c2ccccc2)ccc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.60
KDM4E B2RXH2 2/20 0.59
MCL1 Q07820 2/20 0.59
APAF1 O14727 1/20 0.59
RECQL P46063 1/20 0.59
CASP6 P55212 1/20 0.59
CACNA1B Q00975 1/20 0.59
APBA1 Q02410 1/20 0.59
CASP8 Q14790 1/20 0.59
ALDH1A1 P00352 2/20 0.59
HPGD P15428 1/20 0.59
ACMSD Q8TDX5 3/20 0.58
HNF4A P41235 2/20 0.58
ADRB1 P08588 1/20 0.56
ADRB3 P13945 1/20 0.56
HTT P42858 1/20 0.54
DHFR P00374 1/20 0.53
MKNK1 Q9BUB5 1/20 0.52
MKNK2 Q9HBH9 1/20 0.52
ACLY P53396 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29788086 1.00 CHEK1 (0.60) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL2770512 0.93 ALDH1A1 (0.67) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL17177740 0.89 ALDH1A1 (0.62) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL1921738 0.88 ALDH1A1 (0.57) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL11308149 0.88 CHEK1 (0.59) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL8960746 0.88 PDE4A (0.57) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL10459347 0.87 ALDH1A1 (0.61) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL9534725 0.87 KDM4E (0.66) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL1921213 0.86 ALDH1A1 (0.56) CHEK1KDM4EMCL1APAF1RECQL
SCHEMBL3135122 0.86 CHEK1 (0.60) CHEK1KDM4EMCL1APAF1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118185595-A Surface-modified acid-soluble weighting agent and preparation method and application thereof 中国石油化工股份有限公司 2024-06-14 CN claimed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 US claimed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 US claimed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 WO claimed
WO-2026098560-A2 BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2026-05-15 WO disclosed
CN-118185595-A Surface-modified acid-soluble weighting agent and preparation method and application thereof 中国石油化工股份有限公司 2024-06-14 CN disclosed
CN-114773249-A Compounds, pharmaceutical compositions and methods for treating inflammatory diseases 艾匹克治疗公司 2022-07-22 CN disclosed
CN-113045494-B Pyridone derivative and application thereof in preparation of drugs for preventing and/or treating tuberculosis caused by mycobacterium tuberculosis 四川大学华西医院 2022-04-26 CN disclosed
US-11072582-B2 Substituted pyrrolidines as G-protein coupled receptor 43 agonists EPICS THERAPEUTICS (BE) 2021-07-27 US disclosed
CN-113045494-A Pyridone derivative and application thereof in preparation of drugs for preventing and/or treating tuberculosis caused by mycobacterium tuberculosis 四川大学华西医院 2021-06-29 CN disclosed
WO-2021068950-A1 AMIDE COMPOUND AND MEDICAL USE THEREOF AS STING INHIBITOR 中国药科大学 2021-04-15 WO disclosed
US-20200347016-A1 SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS EPICS THERAPEUTICS (BE) 2020-11-05 US disclosed
CN-1280561-A Amidocarboxylic acid derivatives SANKYO CO (JP) 2001-01-17 CN disclosed
EP-1047765-A1 AQUEOUS CLEANING COMPOSITIONS IN DISPERSED LAMELLAR PHASE THE PROCTER & GAMBLE COMPANY (US) 2000-11-02 EP disclosed
US-6110934-A Substituted benzamide derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. (GB) 2000-08-29 US disclosed
WO-1999061569-A1 ACIDIC CLEANING COMPOSITIONS WITH C10 ALKYL SULFATE DETERGENT SURFACTANT THE PROCTER & GAMBLE COMPANY (US) 1999-12-02 WO disclosed
WO-1999027066-A1 AQUEOUS CLEANING COMPOSITIONS IN DISPERSED LAMELLAR PHASE THE PROCTER & GAMBLE COMPANY (US) 1999-06-03 WO disclosed
EP-0906283-A1 SUBSTITUTED BENZAMIDE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-04-07 EP disclosed
WO-1997048683-A1 SUBSTITUTED BENZAMIDE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1997-12-24 WO disclosed
EP-0319053-A2 Improved phosphate-free detergent bleach compositions UNILEVER N.V. (NL) 1989-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200347016-A1 SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS GPR119, GPR52, GPR88 CHEK1 4598/4885KDM4E 4211/4885MCL1 4342/4885
US-11072582-B2 Substituted pyrrolidines as G-protein coupled receptor 43 agonists GPR119, GPR52, GPR88 CHEK1 4598/4885KDM4E 4211/4885MCL1 4342/4885
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 CHEK1 4635/4885KDM4E 434/4885MCL1 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.